Comparative in vitro activity of nine antistaphylococcal agents against 275 recent isolates of Gram-positive cocci

International Journal of Antimicrobial Agents

Volumn 7, Issue 3, 1996, Pages 167-170

  Ravaoarinoro, Madeleine ^a   Therrien, Christian ^b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b NONE

Author keywords

Antimicrobial agents; Gram positive cocci; In vitro activity

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CEFAZOLIN; CIPROFLOXACIN; ERYTHROMYCIN; FUSIDIC ACID; IMIPENEM; METICILLIN; TEICOPLANIN; VANCOMYCIN;

AGAR GEL DIFFUSION; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CANADA; CONTROLLED STUDY; ENTEROCOCCUS; GRAM POSITIVE COCCI; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TEACHING HOSPITAL;

EID: 0029776694     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(96)00317-2     Document Type: Article

References (18)

1. Brumfitt W, Hamilton-Miller J. Methicillin-resistant Staphylococcus aureus. N Engl J Med 1989;320:1188-1196.
2. Uttley AHC, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci. Lancet 1988;1(8575-6): 57-58.
3. Boyce JM. Methicillin-resistant Staphylococcus aureus: detection, epidemiology and control measures. Infect Dis Clin North Am 1989;3:901-904.
4. Chenowth C, Schaberg D. The epidemiology of enterococci. Eur J Clin Microbiol 1990;9:80-89.
5. McDougal LK, Thornsberry C. The role of β-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins. J Clin Microbiol 1986;23:832-839.
6. Parenti F, Beretta G, Berti M, Arioli V. Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. 1. Description of the producer strain, fermentation studies and biological properties. J Antibiot 1978;31:276-283.
7. Somma S, Gastaldo L, Corti A. Teicoplanin, a new antibiotic from Actinoplanes teichomyceticus nov. sp. Antimicrob Agents Chemother 1984;26:917-923.
8. Greenwood D. Microbiological properties of teicoplanin. J Antimicrob Chemother 1988;21(suppl A):1-13.
9. Steers E, Foltz L, Graves BS. An inocula replicating apparatus for routine testing of bacterial susceptibility to antibiotics. Antibiot Chemother 1959;9:307-311.
10. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. Standard M7-AE. Villanova, PA: National Committee for Clinical Laboratory Standards, 1994.
11. Woodford N, Johnson AP, George RC. Detection of glycopeptide in clinical isolates of Gram-positive bacteria. J Antimicrob Chemother 1991;28:483-490.
12. Maple AC, Hamilton-Miller JMT, Brumfitt W. World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus. Lancet 1989;i:537-539.
13. Harnett N, Brown S, Krishnan C. Emergence of quinolone resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in Ontario, Canada. Antimicrob Agents Chemother 1991;35:1911-1913.
14. [14) Latham RH, Zeleznik D, Minshew BH, Schoenknecht FD, Stamm WE. Staphylococcus saprophyticus β-lactamase production and disk diffusion susceptibility testing for three β-lactam antimicrobial agents. Antimicrob Agents Chemother 1984;6:670-672.
15. Hartman BJ, Tomasz A. Low affinity penicillin-binding protein associated with β-lactam resistance in Staphylococcus. J Bacteriol 1986;158:513-516.
16. Ubukata K, Nonoguchi R, Matsuhashi M, Konno M. Expression and inducibility in Staphylococcus aureus of mecA gene, which encodes methicillin-resistant S. aureus-specific penicillin-binding protein. J Bacteriol 1989;171:2882-2885.
17. Stille WS, Sietzen W, Dieterich HA, Fill JJ. Clinical efficacy and safety of teicoplanin. J Antimicrob Chemother 1988;21(suppl A):69-79.
18. Pohlod DJ, Saravoiatz LD, Somerville MM. In vitro susceptibility of Gram-positive cocci to LY 146032 teicoplanin, sodium fusidate, vancomycin and rifampicin. J Antimicrob Chemother 1987;20:197-202.